Perrigo (PRGO) Other Accumulated Expenses (2023 - 2026)
Perrigo's (PRGO) quarterly Other Accumulated Expenses came in at $234.7 million in Q1 2026, up 1.78% on a QoQ basis from $230.6 million in Q4 2025.
Perrigo (PRGO) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Perrigo (PRGO) has 4 years of Other Accumulated Expenses data on file, last reported at $234.7 million in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $234.7 million in Q1 2026; TTM through Mar 2026 was $234.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $230.6 million, down 3.39% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $234.7 million, up from $230.6 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for PRGO reached as high as $335.4 million in Q4 2023 and fell as low as $230.6 million in Q4 2025.
- Historically, Other Accumulated Expenses has averaged $259.8 million across 4 years, with a median of $236.7 million in 2024.
- Across the five-year window, Other Accumulated Expenses declined 28.83% in 2024 and decreased 3.39% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $335.4 million in 2023, then retreated by 28.83% to $238.7 million in 2024, then declined by 3.39% to $230.6 million in 2025, then rose by 1.78% to $234.7 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $234.7 million in Q1 2026, $230.6 million in Q4 2025, and $238.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 234.70 Mn |
| Dec 31, 2025 | 230.60 Mn |
| Dec 31, 2024 | 238.70 Mn |
| Dec 31, 2023 | 335.40 Mn |